Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Effects of Variability in Blood Pressure, Glucose, and Cholesterol Concentrations, and Body Mass Index on End-Stage Renal Disease in the General Population of Korea.

Kim MK, Han K, Kim HS, Park YM, Kwon HS, Yoon KH, Lee SH.

J Clin Med. 2019 May 27;8(5). pii: E755. doi: 10.3390/jcm8050755.

2.

Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.

Kim MK, Han K, Park YM, Kwon HS, Kang G, Yoon KH, Lee SH.

Circulation. 2018 Dec 4;138(23):2627-2637. doi: 10.1161/CIRCULATIONAHA.118.034978.

PMID:
30571256
3.

Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study.

Kim MK, Han K, Koh ES, Kim HS, Kwon HS, Park YM, Yoon KH, Lee SH.

Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1963-1970. doi: 10.1161/ATVBAHA.117.309803. Epub 2017 Aug 31.

4.

Visit-to-visit variability of metabolic parameters and risk of heart failure: A nationwide population-based study.

Kwon S, Lee SR, Choi EK, Lee SH, Han KD, Lee SY, Yang S, Park J, Choi YJ, Lee HJ, Moon I, Lee E, Cha MJ, Lim WH, Oh S.

Int J Cardiol. 2019 Jun 20. pii: S0167-5273(19)32002-9. doi: 10.1016/j.ijcard.2019.06.035. [Epub ahead of print]

PMID:
31253527
5.

Effect of the variability of blood pressure, glucose, total cholesterol, and body mass index on risk of atrial fibrillation in a healthy population.

Lee SR, Choi EK, Han KD, Lee SH, Oh S.

Heart Rhythm. 2019 Jul 9. pii: S1547-5271(19)30638-1. doi: 10.1016/j.hrthm.2019.07.006. [Epub ahead of print]

PMID:
31299298
6.

Intra-individual variability in high density lipoprotein cholesterol and risk of end-stage renal disease: A nationwide population-based study.

Koh ES, Kim M, Kim MK, Han K, Shin SJ, Kwon HS, Park CW, Park YG, Chung S.

Atherosclerosis. 2019 Jul;286:135-141. doi: 10.1016/j.atherosclerosis.2019.05.018. Epub 2019 May 24.

PMID:
31158787
7.
8.

Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up.

Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K.

PLoS One. 2015 Aug 31;10(8):e0135052. doi: 10.1371/journal.pone.0135052. eCollection 2015.

9.

Variability in metabolic parameters and risk of dementia: a nationwide population-based study.

Lee SH, Han K, Cho H, Park YM, Kwon HS, Kang G, Yoon KH, Kim MK.

Alzheimers Res Ther. 2018 Oct 27;10(1):110. doi: 10.1186/s13195-018-0442-3.

10.

Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.

Zitt E, Pscheidt C, Concin H, Kramar R, Lhotta K, Nagel G.

PLoS One. 2016 Aug 18;11(8):e0161376. doi: 10.1371/journal.pone.0161376. eCollection 2016.

11.

Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.

Bowe B, Xie Y, Xian H, Li T, Al-Aly Z.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):603-613. doi: 10.2215/CJN.09710916. Epub 2017 Mar 27.

12.

Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K, Calderon-Margalit R.

Arch Intern Med. 2012 Nov 26;172(21):1644-50.

13.

Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.

Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, Kovesdy CP.

J Am Coll Cardiol. 2016 Sep 27;68(13):1375-1386. doi: 10.1016/j.jacc.2016.06.054.

14.

Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S.

Kidney Int. 2004 May;65(5):1870-6.

15.

Pre-end-stage renal disease visit-to-visit systolic blood pressure variability and post-end-stage renal disease mortality in incident dialysis patients.

Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP.

J Hypertens. 2017 Sep;35(9):1816-1824. doi: 10.1097/HJH.0000000000001376.

16.
17.

The association between body mass index and mortality on peritoneal dialysis: a prospective cohort study.

Kim YK, Kim SH, Kim HW, Kim YO, Jin DC, Song HC, Choi EJ, Kim YL, Kim YS, Kang SW, Kim NH, Yang CW.

Perit Dial Int. 2014 Jun;34(4):383-9. doi: 10.3747/pdi.2013.00008. Epub 2014 Mar 1.

18.

Total cholesterol variability and risk of atrial fibrillation: A nationwide population-based cohort study.

Roh E, Chung HS, Lee JS, Kim JA, Lee YB, Hong SH, Kim NH, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi KM.

PLoS One. 2019 Apr 24;14(4):e0215687. doi: 10.1371/journal.pone.0215687. eCollection 2019.

19.

Risk factors for end-stage renal disease: 25-year follow-up.

Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS.

Arch Intern Med. 2009 Feb 23;169(4):342-50. doi: 10.1001/archinternmed.2008.605.

20.

Variability in Total Cholesterol Concentration Is Associated With the Risk of Dementia: A Nationwide Population-Based Cohort Study.

Chung HS, Lee JS, Kim JA, Roh E, Lee YB, Hong SH, Kim NH, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi KM.

Front Neurol. 2019 May 7;10:441. doi: 10.3389/fneur.2019.00441. eCollection 2019.

Supplemental Content

Support Center